"Biological Therapy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Treatment of diseases with biological materials or biological response modifiers, such as the use of GENES; CELLS; TISSUES; organs; SERUM; VACCINES; and humoral agents.
| Descriptor ID |
D001691
|
| MeSH Number(s) |
E02.095
|
| Concept/Terms |
Biological Therapy- Biological Therapy
- Biological Therapies
- Therapies, Biological
- Therapy, Biological
- Biologic Therapy
- Biologic Therapies
- Therapies, Biologic
- Therapy, Biologic
- Biotherapy
- Biotherapies
|
Below are MeSH descriptors whose meaning is more general than "Biological Therapy".
Below are MeSH descriptors whose meaning is more specific than "Biological Therapy".
This graph shows the total number of publications written about "Biological Therapy" by people in this website by year, and whether "Biological Therapy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 1 | 2 |
| 2015 | 1 | 1 | 2 |
| 2016 | 3 | 0 | 3 |
| 2017 | 22 | 14 | 36 |
| 2018 | 21 | 14 | 35 |
| 2019 | 5 | 5 | 10 |
| 2020 | 6 | 12 | 18 |
| 2021 | 5 | 1 | 6 |
To return to the timeline, click here.
Below are the most recent publications written about "Biological Therapy" by people in Profiles.
-
The Effect of COVID-19 Resurgence on Morbidity and Mortality in Patients With IBD on Biologic Therapy. Inflamm Bowel Dis. 2021 07 27; 27(8):e90.
-
Impact of COVID-19 on initiation of biologic therapy prescriptions for chronic inflammatory diseases. Joint Bone Spine. 2022 01; 89(1):105253.
-
Lower incidence of COVID-19 in patients with inflammatory bowel disease treated with non-gut selective biologic therapy. J Gastroenterol Hepatol. 2021 Nov; 36(11):3050-3055.
-
Biological therapies in children with rheumatic diseases during the COVID-19 pandemic: A single-centre experience. Int J Clin Pract. 2021 Jul; 75(7):e14030.
-
Seroprevalence of SARS-CoV2 in IBD Patients Treated with Biologic Therapy. J Crohns Colitis. 2021 May 04; 15(5):864-868.
-
Incidence and prognosis of COVID-19 in psoriasis patients on biologic therapy: a multicentre retrospective cohort study. J Eur Acad Dermatol Venereol. 2021 Aug; 35(8):e485-e487.
-
Safety of Biological Therapy in Children With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2021 05 01; 72(5):736-741.
-
Prevalence and Influence of COVID-19 in Asthma Control and Lung Function in Severe Asthma Patients Receiving Biological Treatment. J Investig Allergol Clin Immunol. 2021 Jul 26; 31(4):362-363.
-
SARS-CoV-2 vaccines and biological treatments: dermatological perspectives. Ital J Dermatol Venerol. 2021 Apr; 156(2):118-120.
-
How lockdown measures, during COVID-19 pandemic, matter on psoriatic patient's perception: Study on 600 patients on biologic therapy. J Infect Public Health. 2021 Jul; 14(7):878-882.